According to the latest data from the Hong Kong Stock Exchange, on November 24, JPMorgan increased its holdings in INNOVENT BIO (01801) by 1,635,942 shares at HK$90.9102 per share, totaling approximately HK$149 million. After the transaction, JPMorgan's total holdings in the company reached about 87.16 million shares, representing a 5.08% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.